Cardiovascular and cerebrovascular disease risks are almost doubled when the hypertensive patient is also affected by diabetes mellitus. Lowering of blood pressure markedly decreases the rate of cardiovascular events and renal deterioration in these patients.1 Recent comparative studies in diabetes suggest that, for the prevention of cardiovascular events, angiotensin converting (ACE) inhibitors may be superior to alternative antihypertensive agents, independently of their antihypertensive effect
Derosa, G., Cicero, A.f., Mugellini, A., Ciccarelli, L., Fogari, R. (2003). Perindopril and Candesartan comparative efficacy and safety in type 2 diabetic hypertensive patients. JOURNAL OF HUMAN HYPERTENSION, 17(6), 433-435 [10.1038/sj.jhh.1001572].
Perindopril and Candesartan comparative efficacy and safety in type 2 diabetic hypertensive patients
Cicero AFSecondo
Writing – Original Draft Preparation
;
2003
Abstract
Cardiovascular and cerebrovascular disease risks are almost doubled when the hypertensive patient is also affected by diabetes mellitus. Lowering of blood pressure markedly decreases the rate of cardiovascular events and renal deterioration in these patients.1 Recent comparative studies in diabetes suggest that, for the prevention of cardiovascular events, angiotensin converting (ACE) inhibitors may be superior to alternative antihypertensive agents, independently of their antihypertensive effectI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
